KCNAB2 Antibody - #DF13103
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF13103, RRID:AB_2846063.
折りたたみ/展開
AKR6A5; HKv beta 2; HKvbeta 2; HKvbeta2; HKvbeta2.1; HKvbeta2.2; K(+) channel subunit beta 2; K+ channel beta 2 subunit; KCNA 2B; KCNA2B; KCNAB 2; KCNAB2; KCNK 2; KCNK2; Kv beta2; Kvbeta2; MGC117289; Potassium channel shaker chain beta 2; Potassium voltage gated channel shaker related subfamily; Potassium voltage gated channel shaker related subfamily beta member 2; potassium voltage-gated channel, shaker-related subfamily, beta member 1; Voltage gated potassium channel beta 2 subunit; Voltage gated potassium channel subunit beta 2;
免疫原
Detected in myelinated nerve fibers in the spinal cord, in the juxtaparanodal region of the nodes of Ranvier, but also in the paranodal region (PubMed:11086297). Detected in hippocampus (at protein level) (PubMed:21357749). Detected in hippocampus (PubMed:7649300).
- Q13303 KCAB2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MYPESTTGSPARLSLRQTGSPGMIYSTRYGSPKRQLQFYRNLGKSGLRVSCLGLGTWVTFGGQITDEMAEQLMTLAYDNGINLFDTAEVYAAGKAEVVLGNIIKKKGWRRSSLVITTKIFWGGKAETERGLSRKHIIEGLKASLERLQLEYVDVVFANRPDPNTPMEETVRAMTHVINQGMAMYWGTSRWSSMEIMEAYSVARQFNLTPPICEQAEYHMFQREKVEVQLPELFHKIGVGAMTWSPLACGIVSGKYDSGIPPYSRASLKGYQWLKDKILSEEGRRQQAKLKELQAIAERLGCTLPQLAIAWCLRNEGVSSVLLGASNADQLMENIGAIQVLPKLSSSIIHEIDSILGNKPYSKKDYRS
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q13303 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Y2 | Phosphorylation | Uniprot | |
S5 | Phosphorylation | Uniprot | |
T6 | Phosphorylation | Uniprot | |
T7 | Phosphorylation | Uniprot | |
S9 | Phosphorylation | Uniprot | |
R12 | Methylation | Uniprot | |
S14 | Phosphorylation | Uniprot | |
T18 | Phosphorylation | Uniprot | |
S20 | Phosphorylation | Uniprot | |
Y25 | Phosphorylation | Uniprot | |
S26 | Phosphorylation | Uniprot | |
T27 | Phosphorylation | Uniprot | |
R28 | Methylation | Uniprot | |
S31 | Phosphorylation | Uniprot | |
K44 | Ubiquitination | Uniprot | |
S111 | Phosphorylation | Uniprot | |
S112 | Phosphorylation | Uniprot | |
K124 | Acetylation | Uniprot | |
K124 | Ubiquitination | Uniprot | |
K134 | Ubiquitination | Uniprot | |
Y184 | Phosphorylation | Uniprot | |
K224 | Ubiquitination | Uniprot | |
K235 | Ubiquitination | Uniprot | |
S266 | Phosphorylation | P17252 (PRKCA) | Uniprot |
K268 | Ubiquitination | Uniprot | |
K274 | Acetylation | Uniprot | |
K274 | Ubiquitination | Uniprot | |
K276 | Acetylation | Uniprot | |
K276 | Ubiquitination | Uniprot | |
K290 | Ubiquitination | Uniprot | |
K358 | Ubiquitination | Uniprot | |
Y360 | Phosphorylation | Uniprot | |
K362 | Acetylation | Uniprot | |
K362 | Ubiquitination | Uniprot | |
K363 | Ubiquitination | Uniprot |
研究背景
Cytoplasmic potassium channel subunit that modulates the characteristics of the channel-forming alpha-subunits. Contributes to the regulation of nerve signaling, and prevents neuronal hyperexcitability (By similarity). Promotes expression of the pore-forming alpha subunits at the cell membrane, and thereby increases channel activity (By similarity). Promotes potassium channel closure via a mechanism that does not involve physical obstruction of the channel pore. Promotes KCNA4 channel closure. Modulates the functional properties of KCNA5 (By similarity). Enhances KCNB2 channel activity (By similarity). Binds NADPH and has NADPH-dependent aldoketoreductase activity (By similarity). Has broad substrate specificity and can catalyze the reduction of methylglyoxal, 9,10-phenanthrenequinone, prostaglandin J2, 4-nitrobenzaldehyde, 4-nitroacetophenone and 4-oxo-trans-2-nonenal (in vitro) (By similarity).
Phosphorylated by PRKCZ; may be regulated by incorporation in a complex composed of PRKCZ and SQSTM1.
Cytoplasm. Membrane>Peripheral membrane protein>Cytoplasmic side. Cell membrane>Peripheral membrane protein>Cytoplasmic side. Cell projection>Axon. Cell junction>Synapse>Synaptosome. Cytoplasm>Cytoskeleton.
Note: Recruited to the cytoplasmic side of the cell membrane via its interaction with pore-forming potassium channel alpha subunits. Associates with microtubules when unphosphorylated.
Detected in myelinated nerve fibers in the spinal cord, in the juxtaparanodal region of the nodes of Ranvier, but also in the paranodal region. Detected in hippocampus (at protein level). Detected in hippocampus.
Homotetramer (By similarity). Interaction with tetrameric potassium channel alpha subunits gives rise to a heterooctamer (By similarity). Identified in potassium channel complexes containing KCNA1, KCNA2, KCNA4, KCNA5, KCNA6, KCNAB1 and KCNAB2 (By similarity). Interacts with KCNA1. Interacts with KCNA2. Interacts with KCNA4 and KCND3 (By similarity). Interacts with KCNA5 (By similarity). Interacts with KCNB2 (By similarity). Interacts (in unphosphorylated form) with MAPRE1 (By similarity). Forms a ternary complex with SQSTM1 and PRKCZ (By similarity).
In contrast to KCNAB1, the shorter N-terminal domain of KCNAB2 cannot mediate closure of delayed rectifier potassium channels by physically obstructing the pore.
Belongs to the shaker potassium channel beta subunit family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.